{
  "_id": "68028e9e3ccffd1c7912c93d",
  "ipo_id": "2023_remus_pharmaceuticals_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T17:33:43.042Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/remus-pharmaceuticals-ipo/1419/"
  },
  "about": {
    "details": "<p>Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs.</p>\n<p>The product offerings of the company can be classified into two major categories:</p>\n<ul>\n<li>APIs: Active Pharmaceutical Ingredient (API) is the biologically active component of a drug product (tablet, capsule, cream, injectable) that produces the intended effects.</li>\n<li>Finished Pharmaceutical Formulations: Finished pharmaceutical formulations are therapeutic drugs available in different dosage forms.</li>\n</ul>\n<p>The product portfolio consists of 429 products, as on January 31, 2023. They operate under different brand names across the globe. As on January 31, 2023, the company has 295 products registered in a total of 13 countries. As on January 31, 2023, a total of 134 ;products are under the process of registration in 16 countries.</p>\n<p>As on January 31, 2023, Remus Pharmaceuticals had business-to-business supply agreements with 58 domestic distributors and 139 international distributors for distribution and/or contract manufacturing supply.</p>\n<p>The company has cultivated strong and dependable customer relationships and its clients are spread in more than 20 countries. These clients range from Generic distributors, regional distributors, and Multinational distributors to Hospitals and Clinics.</p>"
  },
  "additionalTables": [
    {
      "heading": "Company Financials",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "Total Assets",
        "Total Revenue",
        "Profit After Tax",
        "Net Worth",
        "Reserves and Surplus",
        "Total Borrowing"
      ],
      "rows": [
        [
          "31-Mar-20",
          "530.36",
          "1276.89",
          "81.16",
          "202.03",
          "201.03",
          "35.93"
        ],
        [
          "31-Mar-21",
          "1104.96",
          "1922.45",
          "102.58",
          "304.61",
          "303.61",
          "27.89"
        ],
        [
          "31-Mar-22",
          "1590.93",
          "2543.71",
          "338.57",
          "643.17",
          "543.17",
          "19.17"
        ],
        [
          "31-Dec-22",
          "3352.96",
          "3361.20",
          "643.90",
          "1712.07",
          "1603.57",
          "947.45"
        ]
      ]
    },
    {
      "heading": "Remus Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "remus_pharmaceuticals_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "71.44%"
        ],
        [
          "ROCE",
          "69.99%"
        ],
        [
          "Debt/Equity",
          "0.03"
        ],
        [
          "RoNW",
          "52.64%"
        ]
      ]
    },
    {
      "heading": "Remus Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "remus_pharmaceuticals_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "33.86",
          null
        ],
        [
          "P/E (x)",
          "21.09",
          null
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Remus Pharmaceuticals IPO raises Rs 13.58 crore from anchor investors. Remus Pharmaceuticals IPO Anchor bid date is May 16 2023. Remus Pharmaceuticals IPO Anchor Investors list",
    "list_link": {
      "text": "Remus Pharmaceuticals IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/ipo_notes/remus-pharmaceuticals-anchor-allocation-report.pdf"
    },
    "details": {
      "ipo_date": "August 22 2023",
      "shares_offered": "110500",
      "anchor_portion_size": "13.58"
    }
  },
  "basicDetails": {
    "ipoDate": "May 17, 2023 to May 19, 2023",
    "ipoListingDate": "Mon, May 29, 2023",
    "faceValue": "₹10 per share",
    "issuePrice": "₹1,229.00",
    "lotSize": "100 Shares",
    "issueSize": "3,88,000 shares (aggregating up to ₹47.69 Cr)",
    "freshIssue": "3,88,000 shares (aggregating up to ₹47.69 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "NSE SME",
    "marketMakerPortion": {
      "text": "19,500 shares",
      "maker_name": "Sunflower Broking Private Limited",
      "maker_url": "https://www.chittorgarh.com/report/ipo-market-maker-vs-listing-gain/127/357/"
    },
    "ipoOpenDate": "Wed, May 17, 2023",
    "ipoCloseDate": "Fri, May 19, 2023",
    "initiationOfRefunds": "Thu, May 25, 2023",
    "creditOfSharesToDemat": "Fri, May 26, 2023",
    "shareHoldingPreIssue": "10,85,000 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "10,85,000 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "92.82%"
      }
    ],
    "shareHoldingPostIssue": "14,73,000 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "14,73,000 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "68.37%"
      }
    ]
  },
  "closing_date": "2023-05-18T18:30:00.000Z",
  "contactDetails": {
    "phone": "+079- 2999 9857",
    "email": "cs@remuspharma.com",
    "full_address": "Remus Pharmaceuticals Limited, 1101 to 1103 South Tower One 42, B/H Ashok Vatika Nr. Jayantilal Park BRTS, Ambli bopal Road Ahmedabad - 380054",
    "website": "http://www.remuspharma.com/"
  },
  "createdAt": "2025-04-18T17:40:46.057Z",
  "faqs": [
    {
      "question": "What is the Remus Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Remus Pharmaceuticals IPO<!-- --> is a <b>SME<!-- --> <!-- -->IPO<!-- --> of <!-- -->388000<!-- --> equity shares</b> of the face value of ₹<!-- -->10<!-- --> aggregating up to ₹<!-- -->47.69<!-- --> Crores. The issue is priced at <span>₹1229 per share</span>. The minimum order quantity is <!-- -->100<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->May 17, 2023</b>, and <b>closes on <!-- -->May 19, 2023</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->NSE SME<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Remus Pharmaceuticals IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Remus Pharmaceuticals IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Remus Pharmaceuticals IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Remus Pharmaceuticals IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Remus Pharmaceuticals IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Remus Pharmaceuticals IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Remus Pharmaceuticals IPO opens on May 17, 2023 and closes on May 19, 2023.</p></div>"
    },
    {
      "question": "What is the lot size of Remus Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>Remus Pharmaceuticals IPO<!-- --> <b>lot size is <!-- -->100</b>, and the <b>minimum amount required is <span>₹1,22,900</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Remus Pharmaceuticals IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Remus Pharmaceuticals IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Remus Pharmaceuticals IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Remus Pharmaceuticals IPO<!-- --> will be done on <!-- -->Wednesday, May 24, 2023<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Friday, May 26, 2023<!-- -->. Check the <a href=\"/ipo_allotment_status/remus-pharmaceuticals-ipo/1419/\" title=\"Remus Pharmaceuticals IPO Allotment Status\">Remus Pharmaceuticals IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Remus Pharmaceuticals IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Remus Pharmaceuticals IPO<!-- --> listing date is on <b>Monday, May 29, 2023</b>.</p></div>"
    }
  ],
  "ipoName": "Remus Pharmaceuticals",
  "issue_price": "₹1,229.00",
  "issue_price_numeric": 1,
  "issue_size": "3,88,000 shares (aggregating up to ₹47.69 Cr)",
  "issue_size_numeric": 3,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Beeline Capital Advisors Pvt Ltd",
      "url": "/report/ipo-lead-manager-review/112/192/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/192/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "nse_sme": "1229.00"
      },
      "open": {
        "nse_sme": "1711.25"
      },
      "low": {
        "nse_sme": "1711.25"
      },
      "high": {
        "nse_sme": "1796.80"
      },
      "last_trade": {
        "nse_sme": "1796.80"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      }
    ],
    "ipo_date": "May 29 2023",
    "nse_symbol": "REMUS",
    "isin": "INE0O5T01011",
    "final_issue_price": "1229 per share"
  },
  "listing_date": "2023-05-28T18:30:00.000Z",
  "listing_gains": "46.20%",
  "listing_gains_numeric": 46.2,
  "logo": "https://www.chittorgarh.net/images/ipo/remus-pharmaceuticals-limited-logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/remus-pharmaceuticals-limited-logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 100 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "100",
        "amount": "122900"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "1",
        "shares": "100",
        "amount": "122900"
      },
      "hni_min": {
        "application": "HNI (Min)",
        "lots": "2",
        "shares": "200",
        "amount": "245800"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/remus-pharmaceuticals-ipo/1419/"
    }
  },
  "lot_size": 100,
  "opening_date": "2023-05-16T18:30:00.000Z",
  "pageHeading": "Remus Pharmaceuticals Limited IPO (Remus Pharmaceuticals IPO) Detail",
  "pageTitle": "Remus Pharmaceuticals IPO Date, Price, GMP, Details",
  "promoterHolding": {
    "promoters": "Mr. Arpit Deepakkumar Shah Ms. Roma Vinodbhai Shah Mr. Swapnil Jatinbhai Shah and Mrs. Anar Swapnil Shah are the Promoters of the company.",
    "holdings": {
      "share_holding_pre_issue": "92.82%",
      "share_holding_post_issue": "68.37%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Remus Pharmaceuticals IPO DRHP",
      "url": "https://nsearchives.nseindia.com/emerge/corporates/content/RemusPharma_DRHP.pdf"
    },
    {
      "text": "Remus Pharmaceuticals IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/may-2023/remus-pharmaceuticals-limited_78894.html"
    },
    {
      "text": "Anchor Investors in Remus Pharmaceuticals IPO",
      "url": "https://www.chittorgarh.net/reports/ipo_notes/remus-pharmaceuticals-anchor-allocation-report.pdf"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "0",
        "neutral": "0",
        "avoid": "1"
      },
      "membersmembers": {
        "subscribe": "2",
        "neutral": "1",
        "avoid": "2"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/remus-pharmaceuticals-ipo/1419/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "remuspharmaceuticals.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Remus Pharmaceuticals IPO offers 407500 shares. 138750 (34.05%) to QIB 41625 (10.21%) to NII 97125 (23.83%) to RII 110500 (27.12%) to Anchor investors.",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "110500 (27.12%)"
      },
      {
        "investor_category": "Market Maker Shares Offered",
        "shares_offered": "19500 (4.79%)"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "138750 (34.05%)"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "41625 (10.21%)"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "97125 (23.83%)"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "407500 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T17:40:46.056Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Remus Pharmaceuticals IPO is subscribed 57.21 times on May 19 2023 7:29:00 PM (Day 3). The public issue subscribed 49.81 times in the retail category 10.75 times in the QIB category and 229.31 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "10.75",
        "shares_offered": "138750",
        "shares_bid_for": "1492000"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "229.31",
        "shares_offered": "41625",
        "shares_bid_for": "9545000"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "49.81",
        "shares_offered": "97125",
        "shares_bid_for": "4837600"
      },
      "total": {
        "category": "Total",
        "subscription_times": "57.21",
        "shares_offered": "277500",
        "shares_bid_for": "15874600"
      }
    },
    "total_applications": "48376",
    "notes": "*Market Maker portion is not included to NII/HNI."
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on May 19 2023",
    "tentative_allotment": "Wed May 24 2023",
    "initiation_of_refunds": "Thu May 25 2023",
    "credit_of_shares_to_demat": "Fri May 26 2023"
  },
  "updatedAt": "2025-04-19T04:37:44.050Z",
  "updated_at": "2025-04-18T17:40:46.056Z",
  "year": 2023,
  "worst_listing_gains": "46.20%",
  "worst_listing_gains_numeric": 46.2
}